Uniphos Enterprises Limited (UNIENTER.NS)
INR 177.0
(-1.71%)
INR 177.0
(-1.71%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 395.3 Million | -14.66 Million | 5.2 Million | -45.87 Million | -21.06 Million | -32.13 Million |
| Net Income | 386.14 Million | 396.21 Million | 539.38 Million | 233.97 Million | 204.27 Million | 211.84 Million |
| Depreciation & Amortization | 8.32 Million | 6.02 Million | 328 Thousand | 345 Thousand | 364 Thousand | 402 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 5.12 Million | 2.81 Million | 2.77 Million | -5.08 Million | 5.33 Million | 2.06 Million |
| Other non-cash items | 9.27 Million | -419.71 Million | -537.28 Million | -275.1 Million | -231.04 Million | -246.44 Million |
| Investing Cash Flow | 73.77 Million | 406.29 Million | 204.34 Million | -338.61 Million | 441.94 Million | -19.41 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -528.1 Million | -452 Million | -739.59 Million | -890.1 Million | -592.4 Million | -695.06 Million |
| Sales/Maturities of investments | 601.87 Million | 386.98 Million | 390 Million | 300 Million | 815.91 Million | 468.74 Million |
| Other Investing Activities | 501.61 Million | 471.3 Million | 553.93 Million | 251.49 Million | 218.42 Million | 206.9 Million |
| Financing Cash Flow | -452.04 Million | -392.93 Million | -236.45 Million | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -452.04 Million | -392.93 Million | -236.45 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -4.84 Million | - | - | - | - | - |
| Accounts payables | 7.93 Million | 2.65 Million | 2.78 Million | -5.33 Million | 5.47 Million | 232 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.04 Million | 159 Thousand | -12 Thousand | 254 Thousand | -131 Thousand | 1.83 Million |
| Cash at beginning of period | 17.9 Million | 16.26 Million | 43.17 Million | 427.66 Million | 6.78 Million | 58.34 Million |
| Cash at end of period | 475.04 Million | 14.95 Million | 16.26 Million | 43.17 Million | 427.66 Million | 6.78 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 457.13 Million | -1.3 Million | -26.91 Million | -384.48 Million | 420.87 Million | -51.55 Million |
| Free Cash Flow | 395.3 Million | -14.66 Million | 5.2 Million | -45.87 Million | -21.06 Million | -32.13 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.47 Million | 386.14 Million | -6.33 Million | -305 Thousand | 393.62 Million | -843 Thousand |
| Depreciation & Amortization | - | 8.32 Million | - | 2.08 Million | 4.16 Million | 2.08 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 5.12 Million | - | - | - | - |
| Other non-cash items | 1.47 Million | 9.27 Million | 6.33 Million | 305 Thousand | -393.62 Million | 843 Thousand |
| Investing Cash Flow | - | 73.77 Million | - | - | 462.6 Million | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -528.1 Million | - | - | - | - |
| Sales/Maturities of investments | - | 601.87 Million | - | - | - | - |
| Other Investing Activities | - | 501.61 Million | - | - | 462.6 Million | - |
| Financing Cash Flow | - | -452.04 Million | - | - | -452.04 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | -452.04 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | -4.84 Million | - | - | - | - |
| Accounts payables | - | 7.93 Million | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 2.04 Million | - | - | - | - |
| Cash at beginning of period | - | 17.9 Million | - | 311.58 Million | 304.92 Million | 17.9 Million |
| Cash at end of period | - | 475.04 Million | - | 315.75 Million | 6.66 Million | 22.07 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | 14.95 Million | - |
| Net cash flow / Change in cash | - | 457.13 Million | - | 4.16 Million | -298.25 Million | 4.16 Million |
| Free Cash Flow | - | 395.3 Million | - | 4.16 Million | -18.84 Million | 4.16 Million |
ESPA3
NIROF
LGO
041960
RMGOF
CLI